Novel Heparanase Inhibitors for Myeloma Treatment: Basic Aspects and Clinical Significance

Grant

Total Award Amount

  • 100000.00
  • Direct Costs

  • 86956.00
  • Sponsor Award Id

  • 2009230
  • Contributor

  • Ralph Sanderson Ph.D.   Principal Investigator